Imago BioSciences Overview
Imago BioSciences (IMGO) has a P/E ratio of -28.58, below the Healthcare sector average of 25.3.
Get informed when a big investor buys or sells
+ Follow-28.58
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Imago BioSciences (IMGO) currently reports a P/E ratio of -28.58. That is below the Healthcare sector average of 25.3. Use the charts on this page to explore Imago BioSciences's P/E ratio history and peer comparisons.
Imago BioSciences's P/E ratio of -28.58 is lower than the Healthcare sector average of 25.3. That is roughly 213.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Imago BioSciences's market price to a fundamental measure such as earnings, sales, or book value. At -28.58, IMGO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -28.58, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.3. From there, open related valuation or income-statement pages for Imago BioSciences, and consider following IMGO for alerts when major investors trade the stock.
Imago BioSciences is classified in the Healthcare sector. On P/E ratio, it currently shows -28.58 versus a sector average near 25.3. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMGO with unrelated industries.
